Karen A. Ter-Akopian

Karen A. Ter-Akopian

Auto-generated profile, based on publicly available information

Karen A. Ter-Akopian

Federal State Budgetary Institution “A.N. Bakulev National Medical Research Center for Cardiovascular Surgery” of the Ministry of Health of the Russian Federation

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Высокотехнологическая медицина
Verified
Journal Article
Closed access
MGMarat Kh. Gurtsiev
Marat Kh. Gurtsiev
MSMarya D. Samsonova
Marya D. Samsonova
KTKaren A. Ter-Akopyan
Karen A. Ter-Akopyan
SASevak G. Antonyan
Sevak G. Antonyan
YZYury Zharikov
Yury Zharikov

19 January 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
VGVilya Gaynitdinova
Vilya Gaynitdinova
SASergey Avdeev
Sergey Avdeev
APA. A. Pozdniakova
A. A. Pozdniakova
AVAnna Vlasenko
Anna Vlasenko
TGT. Yu. Gneusheva
T. Yu. Gneusheva
DAD. U. Allaberdina
D. U. Allaberdina
Introduction. The role of comorbid conditions in susceptibility to SARS-CoV-2 infection and the severity of associated COVID-19 disease has been an area of ongoing research since the pandemic began.Objective. To evaluate the impact of elderly asthma on the clinical course and outcomes of severe COVID-19.Materials and methods. Elderly patients (WHO, 2020) (> 60 years, n = 131) with bronchial asthma (BA) hospitalized for severe COVID-19 were included in the study. The presence of COVID-19 was confirmed by laboratory tests (PCR smear) and/or clinical and radiological examinations. All patients had a history of a confirmed diagnosis of bronchial asthma (GINA, 2020). Follow-up was performed at the hospital stage and for 90 days after discharge from the hospital.Results. In the groups of patients with lethal outcome (regardless of the stage) there were statistically significantly higher Charlson index, respiratory rate, CT lung lesion volume, leukocyte, neutrophil and neutrophil to lymphocyte ratios, lower absolute eosinophil count. In the group of patients who died during hospitalization, severe (IV–V) asthma (p = 0.03), steroid use during the previous year (p = 0.02), chronic heart failure (p = 0.009), and the atopic asthma phenotype was less common (p = 0.02). Those who died in the 90-day posthospital period had greater lung lesion volume on CT scan, and diabetes mellitus was more common (p < 0.001). The most significant predictors of mortality were identified.Conclusion. The common most significant predictors of hospital and 90-day posthospital mortality in older patients with bronchial asthma were comorbidity index and lower eosinophil levels. Hospital mortality is further characterized by a higher neutrophil to lymphocyte ratio and lower total protein; 90-day posthospital mortality by the amount of lung damage on CT scan and the presence of diabetes mellitus.

4 May 2026 in Complex Issues of Cardiovascular Diseases
Verified
Journal Article
Open access
PDF file
EGElena Z. Golukhova
Elena Z. Golukhova
GDGulamjan M. Dadabaev
Gulamjan M. Dadabaev
BSBaizak A. Sagymbayev
Baizak A. Sagymbayev
ISInessa Viktorovna Slivneva
Inessa Viktorovna Slivneva
МММарина Юрьевна Мироненко
Марина Юрьевна Мироненко
БСБайзак Абдрасулович Сагымбаев
Байзак Абдрасулович Сагымбаев
Highlights Transcatheter edge-to-edge mitral valve repair in patients with a «small» mitral annulus and borderline mitral valve area demonstrated high technical success and a low rate of complications. In most cases, a significant reduction of mitral regurgitation to ≤ grade 2 was achieved while maintaining low transmitral gradients, thereby minimizing the risk of iatrogenic mitral stenosis. One-year follow-up outcomes confirmed the durability of both hemodynamic and clinical benefits in the majority of patients. These findings support the feasibility and safety of transcatheter mitral valve repair in carefully selected patients with anatomically «small» mitral valves when performed in specialized high-volume expert centers. Aim. To evaluate the efficacy and safety of transcatheter edge-to-edge mitral valve repair in patients with a «small» mitral annulus and initially limited mitral valve area. Methods. The study included 46 patients with severe mitral regurgitation (grade 3–4) who underwent M-TEER at the A.N. Bakulev National Medical Research Center for Cardiovascular Surgery. The mean age was 68.9 ± 8 years. Most patients had functional MR (atrial or ventricular type) and a “small” mitral annulus with an annular area ranging from 32 to 36 cm² (median 35 cm²), while the mean mitral valve area was 4.1 cm². Clinical and echocardiographic assessments were performed before the procedure, in the early postoperative period, and at 1-year follow-up in 16 patients (34.7%). The evaluation included mitral regurgitation (MR) severity, transmitral pressure gradient, left ventricular remodeling function, and the incidence of complications. Results. Technical success of M-TEER was achieved in 44 of 46 patients (95.6%). Non-fatal in-hospital complications occurred in 3 patients (6.5%), and no procedure-related mortality was observed. In the early postoperative period, MR severity was reduced to ≤ grade 2 in 95.5% of patients; residual severe MR (grade 3) was present in only 4.5%, and no cases of grade 4 MR were recorded. The median mean transmitral gradient increased from 2 to 3 mmHg, remained within a low range, and did not differ between atrial and ventricular MR. At 1-year follow-up (n = 16), 75% of patients still had MR ≤ grade 2, with no cases of grade 4 MR. The mean transmitral gradient remained stable, and left ventricular ejection fraction was preserved or moderately improved, particularly in patients with ventricular MR. No evidence of progressive iatrogenic mitral stenosis was detected. Conclusion. Transcatheter edge-to-edge mitral valve repair in patients with a «small» mitral annulus demonstrated high technical success, a low complication rate, and sustained reduction of mitral regurgitation while maintaining low transmitral gradients. M-TEER may be considered an effective and safe alternative to surgery in high-risk patients with borderline mitral valve area. However, such procedures should be performed in expert, high-volume specialized centers with extensive experience in transcatheter valvular interventions.

17 March 2023 in Ural Medical Journal
Verified
Journal Article
Open access
PDF file
YZYury Zharikov
Yury Zharikov
MGM. Kh. Gurtsiev
M. Kh. Gurtsiev
MSM. D. Samsonova
M. D. Samsonova
KTK. A. Ter-Akopyan
K. A. Ter-Akopyan
PYP. A. Yartsev
P. A. Yartsev
МГМ. Х. Гурциев
М. Х. Гурциев
Introduction. Presently, percutaneous endoscopic gastrostomy is considered to be the operation of choice when long-term enteral feeding in dysphagia syndrome is required. The technique is characterized by low incidence of early and long-term complications due to low traumatic access and operation time. Aim of the work was to assess the risk predictors of percutaneous endoscopic gastrostomy complications and their significance for the postoperative period. Materials and methods. We searched publications and analyzed literature sources using PubMed and MedLine databases and Cochrane Library and elibrary.ru scientific libraries mainly for the last ten years. The search was performed using a set of key words: percutaneous endoscopic gastrostomy, dysphagia syndrome, postoperative complications, risk factors. Results and discussion. The leading and most studied predictors of early and long-term postoperative period complications after gastrostomy are hypoalbuminemia, uncompensated diabetes mellitus, thrombocytopenia, elevated levels of C-reactive protein, Charlson's comorbidity index (4 points or higher), antiaggregant and anticoagulant therapy, morphoconstitutional features of patients. Conclusion. Data analysis has shown that percutaneous endoscopic gastrostomy at high patient flow and gastropectomy supplementation with gastropexy is practically safe and effective if the selection criteria for the operation are observed taking into account the general condition, risk factors and exclusion of absolute contraindications.

25 November 2025 in Kardiologiia
Verified
Journal Article
Open access
PDF file
EGE. Z. Golukhova
E. Z. Golukhova
ISInessa Viktorovna Slivneva
Inessa Viktorovna Slivneva
KPK. V. Petrosyan
K. V. Petrosyan
GDGulamjan M. Dadabaev
Gulamjan M. Dadabaev
BBBektur Sh Berdibekov
Bektur Sh Berdibekov
KTK. A. Ter-Akopyan
K. A. Ter-Akopyan
Aim To study the immediate outcome of an interventional method for the treatment of mitral regurgitation (MR) using the MitraClip system (Abbott Vascular) in the context of the etiological factor. Material and methods This was a prospective, single-center study. A total of 89 patients treated in 2023-2024 were included in the analysis. Most patients belonged to an older age group (67.6 ± 9.3 years) where males predominated (57.3%). Echocardiography (EchoCG) was performed on a Philips EPIQ CVx ultrasound system using X5-1 and X8 t transducers. The severity of MR was assessed by multiparametric EchoCG. Quantitative measurements were performed in accordance with current Guidelines of the American Society of Echocardiography and the European Association of Cardiovascular Imaging (ASE and EACVI, 2015). Results In 19.1% of cases, the cause of MR was mitral valve leaflet chordae prolapse or rupture (primary mitral regurgitation (PMR) group, group 1). In 80.9% of cases, MR was secondary: in 29.2%, MR was atrial functional mitral regurgitation (a-FMR, group 2) and in 51.7%, MR was ventricular FMR (v-FMR, group 3). Comparative analysis of EchoCG data showed that with a comparable MR degree, the left ventricular systolic function was significantly lower in the v-FMR group than in the PMR group, and was also inferior to that in the a-FMR group (42.7±10.2% vs. 53.5±8.5 and 49.2±10.7%, respectively; p 1-3 <0.001, p 2-3 =0.029). The effectiveness of the procedure evident in a reduction of the MR degree was achieved in 93.2% of patients (grade < 1 in 64% of them). The maximum reduction in MR to grade I and less was noted in the v-FMR group (71.7%); this proportion was higher compared to other groups (a-FMR, 57.7%; PMR, 52.9%). All groups had improvements in symptoms and in the NYHA chronic heart failure (CHF) functional class (FC). The v-FMR group achieved a more pronounced symptomatic improvement and a reduction in FC (95.7% of patients with FC II). Conclusion Transcatheter edge-to-edge mitral valve reconstructive procedures using the MitraClip system achieved significant immediate reductions in MR, regardless of its etiology. Long-term follow-up is essential to assess the result sustainability.